×
Log in
Upload File
Most Popular
Study
Business
Design
Technology
Travel
Explore all categories
The top documents tagged [prior chemotherapy]
CALGB 80403 / ECOG 1206: Randomized Phase II Study of Standard Chemotherapy + Cetuximab for Metastatic Esophageal Cancer PC Enzinger, BA Burtness, DR Hollis,
220 views
1 XENOX J. CASSIDY, G.A. BJARNASON, T. HICKISH, C. TOPHAM, M. PROVENCIO, G. BODOKY, L. LANDHERR, P. KORALEWSKI, G. LOPEZ-VIVANCO, G. SAID BEATSON ONCOLOGY
214 views
Study JMDB - A Randomised Phase III Trial of Cisplatin + Pemetrexed vs. Cisplatin + Gemcitabine in Locally Advanced or Metastatic Non-small Cell Lung Cancer
216 views
Immunomodulation in lymphomas Sattva S. Neelapu, M.D. Department of Lymphoma and Myeloma UT MD Anderson Cancer Center Houston, TX Texas Fresh AIR October
229 views
Novel Her-2- neu Targeted Agents Jame Abraham, M.D, FACP Bonnie Wells Wilson Distinguished Professor Chief, Section of Hematology-Oncology West Virginia
222 views
Individualizing Therapy for Gastrointestinal Malignancies 2010 Update Thomas J. Semrad MD, MAS Assistant Professor of Medicine UC Davis Cancer Center
222 views
DOWNSTAGING LOCALLY ADVANCED PANCREATIC ADENOCARCINOMA (LAPC) WITH VASCULAR ENCASEMENT USING PERCUTANEOUS IRREVERSIBLE ELECTROPORATION (IRE) NARAYANAN,GOVINDARAJAN;
220 views
Alessandra Felici, Oncologia Medica A Istituto Regina Elena Rome The near future: molecular targeted therapies for metastatic prostate cancer NEW PERSPECTIVES
217 views
ICTW, Cordoba, Argentina Clinical Research Design & Methodology: Phase II and III Trials Ian Tannock, MD, PhD, DSc Princess Margaret Cancer Centre & University
215 views
Cetuximab plus weekly oxaliplatin/5FU/FA (FUFOX) in 1 st line metastatic gastric cancer. Final results from a multicenter phase II study of the AIO upper
215 views
LUNG CANCER MANAGEMENT METHODS AND PHILOSOPHY DR. D. R. JOSHI B. J. MEDICAL COLLEGE, PUNE
223 views
Resectability and agreement between surgeons: Review of CT- and MRI- scans of the CELIM study (Multicenter randomized trial of cetuximab/FOLFOX versus
222 views
< Prev
Next >